Published in Antimicrob Agents Chemother on January 01, 2003
targetTB: a target identification pipeline for Mycobacterium tuberculosis through an interactome, reactome and genome-scale structural analysis. BMC Syst Biol (2008) 1.84
A balancing act: efflux/influx in mycobacterial drug resistance. Antimicrob Agents Chemother (2009) 1.74
Use of NMR metabolomics to analyze the targets of D-cycloserine in mycobacteria: role of D-alanine racemase. J Proteome Res (2007) 1.17
Genomic and functional analyses of Mycobacterium tuberculosis strains implicate ald in D-cycloserine resistance. Nat Genet (2016) 1.09
Structure of the Mycobacterium tuberculosis D-alanine:D-alanine ligase, a target of the antituberculosis drug D-cycloserine. Antimicrob Agents Chemother (2010) 1.04
Characterisation of ATP-dependent Mur ligases involved in the biogenesis of cell wall peptidoglycan in Mycobacterium tuberculosis. PLoS One (2013) 0.94
Expression, crystallization and preliminary X-ray crystallographic analysis of Xoo0352, D-alanine-D-alanine ligase A, from Xanthomonas oryzae pv. oryzae. Acta Crystallogr Sect F Struct Biol Cryst Commun (2008) 0.88
Identifying feasible metabolic routes in Mycobacterium smegmatis and possible alterations under diverse nutrient conditions. BMC Microbiol (2014) 0.87
Metabolomics Reveal d-Alanine:d-Alanine Ligase As the Target of d-Cycloserine in Mycobacterium tuberculosis. ACS Med Chem Lett (2013) 0.85
Metabolomics analysis identifies d-Alanine-d-Alanine ligase as the primary lethal target of d-Cycloserine in mycobacteria. J Proteome Res (2013) 0.85
Resistance to antibiotics targeted to the bacterial cell wall. Protein Sci (2014) 0.85
A point mutation in cycA partially contributes to the D-cycloserine resistance trait of Mycobacterium bovis BCG vaccine strains. PLoS One (2012) 0.84
Characterization of Escherichia coli D-cycloserine transport and resistant mutants. J Bacteriol (2013) 0.81
Generation and screening of a comprehensive Mycobacterium avium subsp. paratuberculosis transposon mutant bank. Front Cell Infect Microbiol (2014) 0.79
Protein targets for structure-based anti-Mycobacterium tuberculosis drug discovery. Protein Cell (2010) 0.78
Advances in the treatment of pulmonary tuberculosis. J Thorac Dis (2012) 0.77
Glutamate Racemase Is the Primary Target of β-Chloro-d-Alanine in Mycobacterium tuberculosis. Antimicrob Agents Chemother (2016) 0.77
High-Level Heterologous Production of d-Cycloserine by Escherichia coli. Appl Environ Microbiol (2015) 0.75
Identification and characterization of a NaCl-responsive genetic locus involved in survival during desiccation in Sinorhizobium meliloti. Appl Environ Microbiol (2013) 0.75
New use of BCG for recombinant vaccines. Nature (1991) 14.40
Isolation and characterization of efficient plasmid transformation mutants of Mycobacterium smegmatis. Mol Microbiol (1990) 13.71
The envelope of mycobacteria. Annu Rev Biochem (1995) 9.33
Compilation and analysis of DNA sequences associated with apparent streptomycete promoters. Nucleic Acids Res (1992) 4.95
Sequence of the vanC gene of Enterococcus gallinarum BM4174 encoding a D-alanine:D-alanine ligase-related protein necessary for vancomycin resistance. Gene (1992) 3.68
Enzymes in the D-alanine branch of bacterial cell wall peptidoglycan assembly. J Biol Chem (1989) 2.71
Mycobacterium smegmatis: an absurd model for tuberculosis? Trends Microbiol (2001) 2.40
Efflux pump of the proton antiporter family confers low-level fluoroquinolone resistance in Mycobacterium smegmatis. Proc Natl Acad Sci U S A (1996) 2.27
Mechanism of D-cycloserine action: alanine racemase from Escherichia coli W. J Bacteriol (1972) 2.17
Transcription and expression analysis, using lacZ and phoA gene fusions, of Mycobacterium fortuitum beta-lactamase genes cloned from a natural isolate and a high-level beta-lactamase producer. Mol Microbiol (1994) 1.86
Isolation and analysis of restriction endonuclease digestive patterns of chromosomal DNA from Mycobacterium paratuberculosis and other Mycobacterium species. J Clin Microbiol (1987) 1.84
The biochemical mechanisms of resistance by streptococci to the antibiotics D-cycloserine and O-carbamyl-D-serine. Biochemistry (1967) 1.83
Effective immunization against cutaneous leishmaniasis with recombinant bacille Calmette-Guérin expressing the Leishmania surface proteinase gp63. Proc Natl Acad Sci U S A (1993) 1.76
Enhancement of drug susceptibility of Mycobacterium avium by inhibitors of cell envelope synthesis. Antimicrob Agents Chemother (1990) 1.72
Inhibition of bacterial growth by beta-chloro-D-alanine. Proc Natl Acad Sci U S A (1974) 1.38
An efficient and high-yielding method for isolation of RNA from mycobacteria. Biotechniques (1994) 1.34
Phage infection, transfection and transformation of Mycobacterium avium complex and Mycobacterium paratuberculosis. Microbiology (1995) 1.31
ANTAGONISM OF D-CYCLOSERINE INHIBITION OF MYCOBACTERIAL GROWTH BY D-ALANINE. J Bacteriol (1963) 1.31
Overexpression of the D-alanine racemase gene confers resistance to D-cycloserine in Mycobacterium smegmatis. J Bacteriol (1997) 1.28
Mycobacterium smegmatis and tuberculosis. Trends Microbiol (2002) 1.25
Characterization of the alanine racemases from two mycobacteria. FEMS Microbiol Lett (2001) 1.22
Susceptibility of mycobacterial D-alanyl-D-alanine synthetase to D-cycloserine. Am Rev Respir Dis (1969) 1.21
The characterization of an alanine racemase mutant of Escherichia coli. Genet Res (1972) 1.17
Mycobacterium smegmatis D-Alanine Racemase Mutants Are Not Dependent on D-Alanine for Growth. Antimicrob Agents Chemother (2002) 1.10
Resistance to D-cycloserine in the tubercle bacilli: mutation rate and transport of alanine in parental cells and drug-resistant mutants. Appl Microbiol (1971) 1.00
Adverse neurological reactions in patients with multidrug-resistant pulmonary tuberculosis after coadministration of cycloserine and ofloxacin. Clin Infect Dis (1993) 0.94
DOTS and DOTS-plus: not the only answer. Ann N Y Acad Sci (2001) 0.93
Genetic analysis of peptidoglycan biosynthesis in mycobacteria: characterization of a ddlA mutant of Mycobacterium smegmatis. J Bacteriol (2000) 0.92
Synergic activity of D-cycloserine and beta-chloro-D-alanine against Mycobacterium tuberculosis. J Antimicrob Chemother (2001) 0.89
DdlN from vancomycin-producing Amycolatopsis orientalis C329.2 is a VanA homologue with D-alanyl-D-lactate ligase activity. J Bacteriol (1998) 0.85
Characterization of a Mycobacterium smegmatis mutant that is simultaneously resistant to D-cycloserine and vancomycin. Antimicrob Agents Chemother (2000) 0.82
Isolation and characterization of endophytic colonizing bacteria from agronomic crops and prairie plants. Appl Environ Microbiol (2002) 1.99
Johne's disease, inflammatory bowel disease, and Mycobacterium paratuberculosis. Annu Rev Microbiol (2004) 1.98
Predicting the in vivo mechanism of action for drug leads using NMR metabolomics. ACS Chem Biol (2011) 1.11
Mycobacterium smegmatis D-Alanine Racemase Mutants Are Not Dependent on D-Alanine for Growth. Antimicrob Agents Chemother (2002) 1.10
Killing of Mycobacterium avium and Mycobacterium tuberculosis by a mycobacteriophage delivered by a nonvirulent mycobacterium: a model for phage therapy of intracellular bacterial pathogens. J Infect Dis (2002) 1.09
Demonstration of allelic exchange in the slow-growing bacterium Mycobacterium avium subsp. paratuberculosis, and generation of mutants with deletions at the pknG, relA, and lsr2 loci. Appl Environ Microbiol (2008) 1.04
Structure of the Mycobacterium tuberculosis D-alanine:D-alanine ligase, a target of the antituberculosis drug D-cycloserine. Antimicrob Agents Chemother (2010) 1.04
Life and death in bovine monocytes: the fate of Mycobacterium avium subsp. paratuberculosis. Microb Pathog (2007) 1.00
Mycobacterium smegmatis L-alanine dehydrogenase (Ald) is required for proficient utilization of alanine as a sole nitrogen source and sustained anaerobic growth. J Bacteriol (2002) 0.99
The immunogenicity of Mycobacterium paratuberculosis 85B antigen. Med Microbiol Immunol (2002) 0.95
Construction and immunogenicity of recombinant Mycobacterium bovis BCG expressing GP5 and M protein of porcine reproductive respiratory syndrome virus. Vaccine (2002) 0.95
Application of the genome sequence to address concerns that Mycobacterium avium subspecies paratuberculosis might be a foodborne pathogen. Foodborne Pathog Dis (2004) 0.93
Peyer's patch-deficient mice demonstrate that Mycobacterium avium subsp. paratuberculosis translocates across the mucosal barrier via both M cells and enterocytes but has inefficient dissemination. Infect Immun (2010) 0.91
Development of luminescent Mycobacterium avium subsp. paratuberculosis for rapid screening of vaccine candidates in mice. Infect Immun (2006) 0.90
Bovine monocytes and a macrophage cell line differ in their ability to phagocytose and support the intracellular survival of Mycobacterium avium subsp. paratuberculosis. Vet Immunol Immunopathol (2005) 0.89
Immune response of pigs inoculated with Mycobacterium bovis BCG expressing a truncated form of GP5 and M protein of porcine reproductive and respiratory syndrome virus. Vaccine (2004) 0.86
Immunogenicity and reactivity of novel Mycobacterium avium subsp. paratuberculosis PPE MAP1152 and conserved MAP1156 proteins with sera from experimentally and naturally infected animals. Clin Vaccine Immunol (2010) 0.85
Metabolomics analysis identifies d-Alanine-d-Alanine ligase as the primary lethal target of d-Cycloserine in mycobacteria. J Proteome Res (2013) 0.85
Antigenicity of Mycobacterium paratuberculosis superoxide dismutase in mice. FEMS Immunol Med Microbiol (2002) 0.85
Genetic resistance of mice to Mycobacterium paratuberculosis is influenced by Slc11a1 at the early but not at the late stage of infection. Infect Immun (2008) 0.84
Impairment of D-alanine biosynthesis in Mycobacterium smegmatis determines decreased intracellular survival in human macrophages. Microbiology (2009) 0.84
Plasmid transformation and expression of the firefly luciferase in Microbacterium testaceum type and endophytic colonizing field strains. Can J Microbiol (2008) 0.79
Extracellular ATP is cytotoxic to mononuclear phagocytes but does not induce killing of intracellular Mycobacterium avium subsp. paratuberculosis. Clin Vaccine Immunol (2007) 0.77
ATP release by infected bovine monocytes increases the intracellular survival of Mycobacterium avium subsp. paratuberculosis. Comp Immunol Microbiol Infect Dis (2008) 0.77
Development of cyclobutene- and cyclobutane-functionalized fatty acids with inhibitory activity against Mycobacterium tuberculosis. ChemMedChem (2014) 0.75